Albany Molecular Research (AMRI) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. DPZ
2. NVDA
3. BAC
4. GS
5. ACI
6. DRS
7. JPM
8. AVAV
9. UNH
10. ORCL

Go back to Albany Molecular Research (AMRI) Tops Q3 EPS by 1c

AMRI Announces Third Quarter 2015 Results

November 5, 2015 7:02 AM EST

ALBANY, N.Y., Nov. 5, 2015 /PRNewswire/ -- AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30 2015.

Highlights:

Third quarter contract revenue of $101.4 million, a 76% increase from 2014 Adjusted contract margins expand to 25% Third quarter adjusted diluted EPS of $0.14, including a $0.04 decrease in EPS from royalties in the current quarter Operating cash flow of $18.5 million Reiterates Full Year 2015 total revenue of $400 to $416 million; adjusted EPS guidance maintained at between... More